Joan H. De Jong

Amsterdam, NH, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Enterocyte-like differentiation defines metabolic gene signatures of CMS3 colorectal cancers and provides therapeutic vulnerability.

Enterocyte-like differentiation defines metabolic gene signatures of CMS3 colorectal cancers and provides therapeutic vulnerability.

Journal: Nature communications

Published: April 13, 2023

Subtype-specific kinase dependency regulates growth and metastasis of poor-prognosis mesenchymal colorectal cancer.

Subtype-specific kinase dependency regulates growth and metastasis of poor-prognosis mesenchymal colorectal cancer.

Journal: Journal of experimental & clinical cancer research : CR

Published: September 21, 2022

Pre-Operative Decitabine in Colon Cancer Patients: Analyses on WNT Target Methylation and Expression.

Pre-Operative Decitabine in Colon Cancer Patients: Analyses on WNT Target Methylation and Expression.

Journal: Cancers

Published: January 31, 2021

AKT3 Expression in Mesenchymal Colorectal Cancer Cells Drives Growth and Is Associated with Epithelial-Mesenchymal Transition.

AKT3 Expression in Mesenchymal Colorectal Cancer Cells Drives Growth and Is Associated with Epithelial-Mesenchymal Transition.

Journal: Cancers

Published: January 08, 2021

High-grade mesenchymal pancreatic ductal adenocarcinoma drives stromal deactivation through CSF-1.

High-grade mesenchymal pancreatic ductal adenocarcinoma drives stromal deactivation through CSF-1.

Journal: EMBO reports

Published: July 02, 2019

Classification of Colorectal Cancer in Molecular Subtypes by Immunohistochemistry.

Classification of Colorectal Cancer in Molecular Subtypes by Immunohistochemistry.

Journal: Methods in molecular biology (Clifton, N.J.)

Published: March 29, 2018

Capturing colorectal cancer inter-tumor heterogeneity in patient-derived xenograft (PDX) models.

Capturing colorectal cancer inter-tumor heterogeneity in patient-derived xenograft (PDX) models.

Journal: International journal of cancer

Published: February 22, 2018

Practical and Robust Identification of Molecular Subtypes in Colorectal Cancer by Immunohistochemistry.

Practical and Robust Identification of Molecular Subtypes in Colorectal Cancer by Immunohistochemistry.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: March 14, 2016

Durable remission of renal cell carcinoma in conjuncture with graft versus host disease following allogeneic stem cell transplantation and donor lymphocyte infusion: rule or exception?

Durable remission of renal cell carcinoma in conjuncture with graft versus host disease following allogeneic stem cell transplantation and donor lymphocyte infusion: rule or exception?

Journal: PloS one

Published: September 27, 2013

Poor-prognosis colon cancer is defined by a molecularly distinct subtype and develops from serrated precursor lesions.

Poor-prognosis colon cancer is defined by a molecularly distinct subtype and develops from serrated precursor lesions.

Journal: Nature medicine

Published: September 24, 2012

Mutations in the Ras-Raf Axis underlie the prognostic value of CD133 in colorectal cancer.

Mutations in the Ras-Raf Axis underlie the prognostic value of CD133 in colorectal cancer.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: April 13, 2012

Fusion of intestinal epithelial cells with bone marrow derived cells is dispensable for tissue homeostasis.

Fusion of intestinal epithelial cells with bone marrow derived cells is dispensable for tissue homeostasis.

Journal: Scientific reports

Published: October 31, 2011

Showing 1-12 of 12

Last Updated: 09/26/2026